Novartis | NVS - Frais De Vente Et D'Administration

Prix De L'Action
146.88
Variation Quotidienne
-1.10 -0.74%
Mensuellement
-4.59%
Annuel
28.47%
Q2 Prévisions
142.62




Frais De Vente Et D'Administration Changement Date
AbbVie USD 3.58B 316M 2026-03
Amgen USD 1.58B 354M 2026-03
AstraZeneca USD 5.06B 455M 2026-03
Bausch Health Companies USD 813M 12M 2026-03
Biogen USD 554.3M 128.2M 2026-03
Bristol-Myers Squibb USD 1.62B 564M 2026-03
Canopy Growth CAD 28.9M 636K 2025-12
Corcept Therapeutics USD 128.04M 13.3M 2026-03
Drreddys Laboratories INR 26.92B 3.74B 2025-12
Eli Lilly USD 2.93B 198M 2026-03
Gilead Sciences USD 1.78B 425M 2025-12
GlaxoSmithKline GBP 2.12B 558M 2026-03
Glaxosmithkline GBP 3.56B 650.29M 2025-12
J&J USD 6.03B 719M 2026-03
Merck USD 2.67B 180M 2026-03
Novartis USD 3.44B 128M 2025-12
Novartis USD 3.44B 132M 2025-12
Pacira USD 83.88M 7.99M 2026-03
Perrigo USD 255.9M 10.2M 2025-12
Pfizer USD 4.08B 894M 2025-12
Phibro Animal Health USD 78.32M 10.24M 2025-12
Prestige Brands USD 29.67M 1.64M 2025-12
Roche Holding CHF 7.28B 3.99B 2025-12
Sanofi EUR 2.33B 419M 2026-03
Sanofi EUR 2.75B 455M 2025-12
Supernus Pharmaceuticals USD 122.39M 57.29M 2025-12
Zoetis USD 619M 40M 2025-12